Chernett Jorey's Form 4 filing
Starling Oncology, Inc. (DFPH) · filed Mar 17, 2026
- Accession no.
- 0000921895-26-000712
- Filed
- Mar 17, 2026
- Trade date
- Mar 13-17, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.23M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chernett JoreyCIK 0002042077 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Common Stock | PPurchaseAcquired | +263,000 | $2.92 | +$767,960 | 10,115,944 | Direct | |
| Mar 16, 2026 | Common Stock | PPurchaseAcquired | +60,985 | $3.29 | +$200,640.65 | 10,176,929 | Direct | |
| Mar 17, 2026 | Common Stock | PPurchaseAcquired | +75,000 | $3.42 | +$256,500 | 10,251,929 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.